TABLE 2.
Characteristic | No hematoma | Hematoma | p |
---|---|---|---|
No. of patients | 4492 | 22 | |
Age (years) | 54 ± 0.2 | 55 ± 4.2 | 0.44 |
Patient gender | |||
Female | 99.5 % | 0.5 % | 0.61 |
Male | 99.4 % | 0.6 % | |
Target organ | |||
Thyroid | 2375 (99.2 %) | 20 (0.8 %) | <0.001 |
Parathyroid | 2117 (99.9 %) | 2 (0.1 %) | |
Extent of operation | |||
Unilateral | 2322 (99.9 %) | 3 (0.1 %) | 0.002 |
Bilateral | 2049 (99.1 %) | 18 (0.9 %) | |
Extensive | 121 (99.2 %) | 1 (0.8 %) | |
Reoperative neck | 496 (99.4 %) | 3 (0.6 %) | 0.73 |
Antiplatelet use | |||
None | 3367 (99.5 %) | 16 (0.5 %) | 0.045 |
<325 mg aspirin | 669 (99.9 %) | 1 (0.1 %) | |
≥325 mg aspirin | 369 (99.2 %) | 3 (0.8 %) | |
Clopidogrel | 87 (97.8 %) | 2 (2.2 %) | |
Anticoagulant use | |||
None | 4331 (99.6 %) | 16 (0.4 %) | <0.001 |
Oral | 136 (97.8 %) | 3 (2.2 %) | |
Injectable | 25 (89.3 %) | 3 (10.7 %) | |
Use of either medication type | |||
None | 3251 (99.7 %) | 11 (0.3 %) | 0.033 |
One | 1199 (99.2 %) | 10 (0.8 %) | |
Both | 42 (97.7 %) | 1 (2.3 %) |
Data are expressed as mean ± SEM or as n (%)